LexaGene Successfully Completes CRADA with US Army
BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...
Randy Hofmann Jack Regan Development Agreement Excet Inc Technical Group Leader Program Executive Office For Chemical
Source: globenewswire.com